Position in GILD
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$263,797
-$444,202 QoQ
Shares Held
2,088
-58.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#1,748
of 2,265 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Curat Global, LLC holds $5,826,997 across 10 Drug Manufacturers - General names. GILD ranks #6 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
5,380 | $1,353,823 | |
| 2 | AMGN |
Amgen Inc
|
3,403 | $1,232,294 | |
| 3 | LLY |
ELI LILLY & Co
|
1,015 | $1,217,421 | |
| 4 | PFE |
Pfizer Inc
|
28,763 | $692,613 | |
| 5 | MRK |
Merck & Co., Inc.
|
4,752 | $610,632 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
2,088 | $263,797 | |
| 7 | NVO |
Novo Nordisk A S
|
3,830 | $183,610 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
2,723 | $156,899 |
All Filings in GILD
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $263,797 | 2,088 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $707,999 | 5,080 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $623,519 | 5,080 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $563,880 | 5,080 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $563,219 | 5,080 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $569,214 | 5,080 | Shares | Sole | 2025-04-11 | |
| No filing history on record for this holder in this stock. | ||||||